Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-04

Clinical Trial Update: Nutraceutical Efficacy for rUTI [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating a nutraceutical for urinary tract infections was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Urinary Tract Infections | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-02-04